Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab, Temozolomide, and Radiation for Newly-Diagnosed GBM
NCT01013285Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jun 2006
- Primary completion
- Oct 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jun 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT01013285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013285.